Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Depreciation & Amortization (CF) (2016 - 2026)

Crescent Biopharma has reported Depreciation & Amortization (CF) over the past 12 years, most recently at $64000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) changed N/A to $64000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $120000.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $84000.0 for FY2025, N/A changed from the prior year.
  • Depreciation & Amortization (CF) was $64000.0 for Q1 2026 at Crescent Biopharma, up from $54000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $64000.0 in Q1 2026 and troughed at $2000.0 in Q2 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $44778.5 (2022), against an average of $41255.7.
  • Year-over-year, Depreciation & Amortization (CF) dropped 9.72% in 2023 and then plummeted 66.65% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $45718.0 in 2022, then crashed by 49.04% to $23297.0 in 2023, then tumbled by 37.25% to $14620.0 in 2024, then surged by 269.36% to $54000.0 in 2025, then increased by 18.52% to $64000.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIO's Depreciation & Amortization (CF) are $64000.0 (Q1 2026), $54000.0 (Q4 2025), and $2000.0 (Q2 2025).